This article is part of the supplement: Current and new antitumor necrosis factor agents in perspective
Effective use of TNF antagonists
-
Correspondence: David Yocum yocum@u.arizona.edu
Arthritis Res Ther 2004, 6(Suppl 2):S24-S30 doi:10.1186/ar997
Accesses
- Last 30 days: 123 accesses
- Last 365 days: 1526 accesses
- All time: 9092 accesses